JP Morgan Chase’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.8K | Sell |
100
-73,500
| -100% | -$15.5M | ﹤0.01% | 6570 |
|
|
2025
Q4 | $14.6M | Sell |
73,600
-4,500
| -6% | -$909K | ﹤0.01% | 2342 |
|
|
2025
Q3 | $15.9M | Buy |
78,100
+28,100
| +56% | +$4.99M | ﹤0.01% | 2291 |
|
|
2025
Q2 | $8.8M | Sell |
50,000
-106,300
| -68% | -$16M | ﹤0.01% | 2671 |
|
|
2025
Q1 | $21M | Buy |
156,300
+4,300
| +3% | +$566K | ﹤0.01% | 1896 |
|
|
2024
Q4 | $19.2M | Buy |
152,000
+7,000
| +5% | +$1.04M | ﹤0.01% | 2083 |
|
|
2024
Q3 | $24.1M | Buy |
145,000
+140,800
| +3,352% | +$21.3M | ﹤0.01% | 1831 |
|
|
2024
Q2 | $559K | Buy |
+4,200
| New | +$506K | ﹤0.01% | 4631 |
|
|
2024
Q1 | – | Sell |
-3,300
| Closed | -$249K | – | 7881 |
|
|
2023
Q4 | $249K | Buy |
+3,300
| New | +$209K | ﹤0.01% | 5254 |
|
|
2023
Q2 | – | Sell |
-400
| Closed | -$24K | – | 7328 |
|
|
2023
Q1 | $24K | Buy |
+400
| New | +$22.2K | ﹤0.01% | 5942 |
|
|
2022
Q4 | – | Sell |
-1,000
| Closed | -$52K | – | 6996 |
|
|
2022
Q3 | $52K | Buy |
+1,000
| New | +$59.3K | ﹤0.01% | 5540 |
|
|
2021
Q1 | – | Sell |
-260,800
| Closed | -$10.4M | – | 6351 |
|
|
2020
Q4 | $10.4M | Buy |
260,800
+40,300
| +18% | +$1.3M | ﹤0.01% | 2185 |
|
|
2020
Q3 | $5.18M | Sell |
220,500
-2,500
| -1% | -$63.9K | ﹤0.01% | 2532 |
|
|
2020
Q2 | $4.04M | Buy |
223,000
+220,000
| +7,333% | +$4.33M | ﹤0.01% | 2615 |
|
|
2020
Q1 | $43K | Sell |
3,000
-762,000
| -100% | -$21.9M | ﹤0.01% | 4772 |
|
|
2019
Q4 | $29.1M | Sell |
765,000
-50,000
| -6% | -$1.5M | 0.01% | 1300 |
|
|
2019
Q3 | $18M | Sell |
815,000
-50,000
| -6% | -$1.07M | ﹤0.01% | 1665 |
|
|
2019
Q2 | $17.6M | Buy |
865,000
+100,000
| +13% | +$2.3M | ﹤0.01% | 1662 |
|
|
2019
Q1 | $22.1M | Buy |
+765,000
| New | +$18.9M | ﹤0.01% | 1471 |
|
|
2018
Q4 | – | Sell |
-200,000
| Closed | -$5.69M | – | 5941 |
|
|
2018
Q3 | $5.69M | Sell |
200,000
-114,000
| -36% | -$3.76M | ﹤0.01% | 2641 |
|
|
2018
Q2 | $10.5M | Buy |
314,000
+144,000
| +85% | +$4.48M | ﹤0.01% | 2101 |
|
|
2018
Q1 | $4.12M | Buy |
+170,000
| New | +$3.38M | ﹤0.01% | 2745 |
|
|
2017
Q3 | – | Sell |
-100,000
| Closed | -$1.93M | – | 5182 |
|
|
2017
Q2 | $1.93M | Sell |
100,000
-5,000
| -5% | -$87.2K | ﹤0.01% | 3062 |
|
|
2017
Q1 | $1.86M | Sell |
105,000
-40,000
| -28% | -$742K | ﹤0.01% | 3088 |
|
|
2016
Q4 | $2.15M | Buy |
+145,000
| New | +$2.6M | ﹤0.01% | 3024 |
|
|
2016
Q2 | – | Sell |
-12,500
| Closed | -$362K | – | 4947 |
|
|
2016
Q1 | $362K | Buy |
+12,500
| New | +$325K | ﹤0.01% | 3451 |
|
|
2015
Q3 | – | Sell |
-67,500
| Closed | -$3.91M | – | 4078 |
|
|
2015
Q2 | $3.91M | Buy |
+67,500
| New | +$3.45M | ﹤0.01% | 2542 |
|
Other funds holding THC
VPM
VCM
LPC
JP Morgan Chase's THC Position: Q1 2026 in Review
JP Morgan Chase reduced its Tenet Healthcare (THC) stake by 30% in Q1 2026, selling an estimated $26.7M and leaving 295,914 shares worth $55.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1329.
JP Morgan Chase first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $97.7M in Q4 2019. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- JP Morgan Chase held 295,914 shares of Tenet Healthcare worth $55.6M as of Q1 2026.
- JP Morgan Chase sold 126,954 Tenet Healthcare shares in Q1 2026, an estimated $26.7M.
- Tenet Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1329 holding.
- JP Morgan Chase first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Tenet Healthcare position peaked at $97.7M in Q4 2019.
- 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.